Download Free Sample Report

This report contains market size and forecasts of Anti Peptic Ulcer Drugs in global, including the following market information:

• Global Anti Peptic Ulcer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Anti Peptic Ulcer Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Anti Peptic Ulcer Drugs companies in 2021 (%)

The global Anti Peptic Ulcer Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Proton Pump Inhibitors (PPIs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti Peptic Ulcer Drugs include Eisai, Daewoong Pharmaceutical, Takeda Pharmaceutical, HeliCure, AstraZeneca, Ore Holdings, Sihuan Pharmaceutical, GlaxoSmithKline and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Peptic Ulcer Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti Peptic Ulcer Drugs Market Segment Percentages, by Type, 2021 (%)

• Proton Pump Inhibitors (PPIs)
• Potassium-Competitive Acid Blockers (P-CAB)
• Antacids
• H2 Antagonists
• Antibiotics
• Ulcer Protective Drugs

Global Anti Peptic Ulcer Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti Peptic Ulcer Drugs Market Segment Percentages, by Application, 2021 (%)

• Gastritis
• Gastric Ulcers
• Duodenal Ulcers
• Gastroesophageal Reflux Disease (GERD)

Global Anti Peptic Ulcer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Anti Peptic Ulcer Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Anti Peptic Ulcer Drugs revenues share in global market, 2021 (%)
• Key companies Anti Peptic Ulcer Drugs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Anti Peptic Ulcer Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eisai
• Daewoong Pharmaceutical
• Takeda Pharmaceutical
• HeliCure
• AstraZeneca
• Ore Holdings
• Sihuan Pharmaceutical
• GlaxoSmithKline
• Pfizer
• Abbott Laboratories
• Yuhan Corporation
• Cadila Healthcare
• Boehringer Ingelheim